MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages

[1]  P. Lipsky,et al.  Comparison of Tripterygium wilfordii Hook F Versus Sulfasalazine in the Treatment of Rheumatoid Arthritis , 2009, Annals of Internal Medicine.

[2]  Xiaomin Wang,et al.  Triptolide inhibits amyloid-β1-42-induced TNF-α and IL-1β production in cultured rat microglia , 2008, Journal of Neuroimmunology.

[3]  Xiaomin Wang,et al.  Triptolide inhibits COX‐2 expression and PGE2 release by suppressing the activity of NF‐κB and JNK in LPS‐treated microglia , 2008, Journal of neurochemistry.

[4]  H. Lee,et al.  Garlic (Allium sativum) Extract Inhibits Lipopolysaccharide-Induced Toll-Like Receptor 4 Dimerization , 2008, Bioscience, biotechnology, and biochemistry.

[5]  Simmie L. Foster,et al.  Gene-specific control of inflammation by TLR-induced chromatin modifications , 2008, Nature.

[6]  J. Balsinde,et al.  TLR3-Dependent Induction of Nitric Oxide Synthase in RAW 264.7 Macrophage-Like Cells via a Cytosolic Phospholipase A2/Cyclooxygenase-2 Pathway1 , 2007, The Journal of Immunology.

[7]  Ilya Raskin,et al.  Revisiting the ancient concept of botanical therapeutics. , 2007, Nature chemical biology.

[8]  R. Pope,et al.  Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[9]  Hui Yang,et al.  Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. , 2007, Phytochemistry.

[10]  L. Parker,et al.  Translational Mini‐Review Series on Toll‐like Receptors:
Networks regulated by Toll‐like receptors mediate innate and adaptive immunity , 2007, Clinical and experimental immunology.

[11]  E. Jirillo,et al.  Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. , 2006, Current pharmaceutical design.

[12]  Hong-Hee Kim,et al.  Expression profiling of lipopolysaccharide target genes in RAW264.7 cells by oligonucleotide microarray analyses , 2006, Archives of pharmacal research.

[13]  D. Agrawal,et al.  Immunobiology of Toll‐like receptors: Emerging trends , 2006, Immunology and cell biology.

[14]  Nan Li,et al.  Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. , 2006, Biochemical and biophysical research communications.

[15]  L. O’Neill,et al.  Targeting signal transduction as a strategy to treat inflammatory diseases , 2006, Nature Reviews Drug Discovery.

[16]  I. Raskin,et al.  In Vitro and in Vivo Anti-Inflammatory Activity of a Seed Preparation Containing Phenethylisothiocyanate , 2006, Journal of Pharmacology and Experimental Therapeutics.

[17]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[18]  D. Schwartz,et al.  Toll-like receptors in the pathogenesis of human disease , 2004, Nature Immunology.

[19]  T. Krakauer.  Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB. , 2004, Current drug targets. Inflammation and allergy.

[20]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Y. Shoenfeld,et al.  Toll-like Receptors and their Role in the Development of Autoimmune Diseases , 2004, Autoimmunity.

[22]  K. Moore,et al.  Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways , 2004, Nature Medicine.

[23]  Michael Karin,et al.  The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.

[24]  Hisami Ikeda,et al.  Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. , 2003, Pharmacology & therapeutics.

[25]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[26]  K. Dabbagh,et al.  Toll-like receptors and T-helper-1/T-helper-2 responses , 2003, Current opinion in infectious diseases.

[27]  S. Akira,et al.  Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.

[28]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[29]  J. A. Ross,et al.  Triptolide and Chemotherapy Cooperate in Tumor Cell Apoptosis , 2001, The Journal of Biological Chemistry.

[30]  P. Lipsky,et al.  A potential new treatment for rheumatoid arthritis: thunder god vine. , 1997, Seminars in arthritis and rheumatism.